Chronic Lymphocytic Leukemia


Breakthroughs in Chronic Lymphocytic Leukemia from ASH 2011

Published on

Topics include: Treatment

Email this program

Get Link

Dr. Steven Rosen, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, shares his perspective about the latest chronic lymphocytic leukemia (CLL) news from the American Society of Hematology's 2011 annual meeting. Dr. Rosen explores CLL breakthroughs, including a new, non-chemotherapy treatment that may provide a better tolerated approach to treating the disease, especially for older patients and those with genetic variations that do not respond to the current standard of care.

View more programs featuring

Stay Connected, Sign Up for Alerts!

Be the first to know about new programs and information with email alerts.

Featured Blog
CLL and Lymphoma Drug Approvals: Kudos to the FDA

By Andrew Schorr


Page last updated on